causal
Antibiotic development lacks commercial incentive
The failure to develop new antibiotics is not due to a lack of scientific tools but to a lack of commercial incentive, so infection mortality is rising, and policy must reimburse these efforts or the innovation engine stalls.
causalpending
Speaker
TalEvidence Quote
“The likelihood of dying from significant infections continues to go up and it's not a lack of scientific tools to understand bacteria”
Created: 11/19/2026, 4:01:33 PM
Your notes
Loading notes...